Eltrombopag/Why can’t the hospital buy Eltrombopag?

Eltrombopag/ Eltrombopag is an antiplatelet drug used to treat idiopathic thrombocytopenic purpura (ITP) and chronic liver disease-associated thrombocytopenia (CLD-PLT). In these diseases, patients have low platelet counts and are prone to bleeding. Eltrombopag improves symptoms by increasing a patient's platelet count by encouraging the bone marrow to produce more platelets. When using eltrombopag, doctors will develop a personalized medication plan based on the patient's specific conditions, including dosage and treatment time.

Why sometimes the hospital cannot buy Eltrombopag? There may be several reasons. First, supply issues may be one of the main reasons. Because eltrombopag is a specialized drug, its production and supply require a certain amount of time and resources. Secondly, eltrombopag may be an imported drug, and imported drugs are restricted by various factors. For example, there may be import restrictions on certain drugs. These factors may prevent hospitals from purchasing eltrombopag in a timely manner.

In addition, the price of the drug may also affect the hospital's purchase of eltrombopag. The common specifications of Eltrombopag original drug sold in China are25mg*14 tablets and 25mg*28 tablets. The price per box is about more than 2,000-4,000 yuan. Although the drug has entered the reimbursement scope of Class B medical insurance, only patients who meet the indications can be reimbursed. Patients who do not meet the conditions can only purchase the drug at their own expense. There are Turkish and Indian versions of the original drugs sold overseas. The price of each box may be more than 1,000 RMB (the price may fluctuate due to the exchange rate). The price of generic drugs is even lower, which may be several hundred RMB. For information on overseas drug prices and related information, consult Yaode Medical Consultants.